SHORT MINI-FUTURE - ZOETIS | Real-time Boerse Frankfurt Warrants 05:34:19 14/05/2024 pm IST | ||
| 5.38 EUR | -2.00% |
|
| Current month | -12.86% | ||
| 1 month | -25.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 5.38 | -2.00% |
| 13/24/13 | 5.49 | +1.29% |
| 10/24/10 | 5.42 | -2.52% |
| 09/24/09 | 5.56 | -6.08% |
| 08/24/08 | 5.92 | +12.33% |
Real-time Boerse Frankfurt Warrants
Last update May 14, 2024 at 05:34 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | 
Vontobel
|
| WKN | VM6U87 |
| ISIN | DE000VM6U872 |
| Date issued | 11/12/2023 |
| Strike | 227.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.64 € |
|---|---|
| Lowest since issue | 2.37 € |
| Spread | 0.02 € |
| Spread % | 0.37% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.9
USD
Average target price
211
USD
Spread / Average Target
+25.66%
- Stock Market
- Certificates
- Certificat